<div><p>Chronic graft-versus-host disease (cGvHD) is the major source of late phase morbidity and mortality after allogeneic hematopoietic stem cell transplantation. Humanized acute GvHD (aGvHD) <i>in vivo</i> models using NOD-SCID il2rγ-/- (NSG) mice are well described and are important tools for investigating pathogenicity of human cells <i>in vivo</i>. However, there have been only few reported humanized cGvHD mouse models. We evaluated if prolonged inflammation driven by low dose G-CSF-mobilized human PBMCs (G-hPBMCs) would lead to cGvHD following cyclophosphamide (CTX) administration and total body irradiation (TBI) in NSG mice. Engraftment was assessed in peripheral blood (PB) and in specific target organs by either flow cytometry or ...
Graft-versus-host disease (GVHD) is a major complication of allogeneic haematopoietic stem cell tran...
AbstractChronic graft-versus-host disease (cGVHD) is a significant roadblock to long-term hematopoie...
Chronic GVHD (cGVHD) is the major cause of late, nonrelapse death following stem cell transplantatio...
Chronic graft-versus-host disease (cGvHD) is the major source of late phase morbidity and mortality ...
Background: Graft-versus host disease (GVHD) is a complication of stem cell transplantation associat...
Mice bearing a "humanized" immune system are valuable tools to experimentally manipulate human cells...
<div><p>Mice bearing a “humanized” immune system are valuable tools to experimentally manipulate hum...
The occurrence of Graft-versus-Host Disease (GvHD) is a prevalent and potentially lethal complicatio...
NOD.Cg-Prkdcscid IL-2rgtm1Wjl/SzJ (NSG) mice are a valuable tool for studying Graft-versus-Host-Dise...
The occurrence of Graft-versus-Host Disease (GvHD) is a prevalent and potentially lethal complicatio...
BACKGROUND: Graft-versus host disease (GVHD) is a complication of stem cell transplantation associat...
Humanized mouse models can well be modified to study specific aspects of Graft-versus-Host Disease (...
Humanized mouse models can well be modified to study specific aspects of Graft-versus-Host Disease (...
Non clinical assessment of immunotoxicity of human cellular products in vivo is limited by the lack ...
Graft-versus-host disease (GVHD) remains a frequently occurring and difficult-to-treat complication ...
Graft-versus-host disease (GVHD) is a major complication of allogeneic haematopoietic stem cell tran...
AbstractChronic graft-versus-host disease (cGVHD) is a significant roadblock to long-term hematopoie...
Chronic GVHD (cGVHD) is the major cause of late, nonrelapse death following stem cell transplantatio...
Chronic graft-versus-host disease (cGvHD) is the major source of late phase morbidity and mortality ...
Background: Graft-versus host disease (GVHD) is a complication of stem cell transplantation associat...
Mice bearing a "humanized" immune system are valuable tools to experimentally manipulate human cells...
<div><p>Mice bearing a “humanized” immune system are valuable tools to experimentally manipulate hum...
The occurrence of Graft-versus-Host Disease (GvHD) is a prevalent and potentially lethal complicatio...
NOD.Cg-Prkdcscid IL-2rgtm1Wjl/SzJ (NSG) mice are a valuable tool for studying Graft-versus-Host-Dise...
The occurrence of Graft-versus-Host Disease (GvHD) is a prevalent and potentially lethal complicatio...
BACKGROUND: Graft-versus host disease (GVHD) is a complication of stem cell transplantation associat...
Humanized mouse models can well be modified to study specific aspects of Graft-versus-Host Disease (...
Humanized mouse models can well be modified to study specific aspects of Graft-versus-Host Disease (...
Non clinical assessment of immunotoxicity of human cellular products in vivo is limited by the lack ...
Graft-versus-host disease (GVHD) remains a frequently occurring and difficult-to-treat complication ...
Graft-versus-host disease (GVHD) is a major complication of allogeneic haematopoietic stem cell tran...
AbstractChronic graft-versus-host disease (cGVHD) is a significant roadblock to long-term hematopoie...
Chronic GVHD (cGVHD) is the major cause of late, nonrelapse death following stem cell transplantatio...